Back

Serial lipoprotein(a) measurements reclassify cardiovascular risk and identify additional candidates for lipoprotein(a)-lowering therapy

29 August 2026 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Lp(a): new kid on the block! Biomarkers ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Mark Colin Gissler

University of Freiburg, Freiburg (Germany)

6 More presentations in this session

Presentation thumbnail
Intra-individual variability in lipoprotein(a): insights from 922,304 measurements
Mr Y. Vajeeston (Oslo, NO)
Abstract
Presentation thumbnail
A machine learning–derived Lp(a) threshold far below current guideline levels predicts cardiovascular events in japanese PCI patients
Doctor M. Kimura (Yamaguchi, JP)
Abstract
Presentation thumbnail
Added predictive value of Lipoprotein(a) on top of the SMART2 risk model in patients with atherosclerotic cardiovascular disease
Miss T. Reitsma (Utrecht, NL)
Abstract
Presentation thumbnail
Pre-percutaneous coronary intervention lipoprotein (a) levels and its association with angiographically confirmed restenosis – a study level meta-analysis
Doctor H. Rai (Dublin 7, IE)
Abstract
Presentation thumbnail
Comparative impact of cardiometabolic multimorbidity clusters and distinct obesity indicators on cardiovascular disease in chinese middle-aged and older adult
Doctor R. Tang (Zhengzhou, CN)
Abstract

Access the full session

Session thumbnail
Lp(a): new kid on the block!

The Event

Event poster

ESC Congress 2026

29 August 2026 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Dynamic lipoprotein(a) changes in acute coronary syndromes: implications for accurate cardiovascular risk assessment
20 March 2026
thumbnail
Congress Session
Lp(a): not so "little" anymore the role of Lp(a) in cardiovascular risk assessment and clinical practice
31 August 2024
thumbnail
Congress Presentation
The prevalence and accumulation of main cardiometabolic risk factors among the finnish adult population at different levels of lp(a)
4 April 2025
thumbnail
Congress Presentation
Review on clinical strategies for managing patients with elevated Lp(a): Cost-effectiveness of Lp(a) testing and awareness of lifestyle changes via Public Health Policy in absence of targeted therapy
24 June 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources